Yuan M - Search Results

1

Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer.

Wu J, Chen J, Zhao Y, Yuan M, Chen X, He X, Zhang J, Shao G, Sun Q. Wu J, et al. Among authors: yuan m. Mol Pharm. 2024 Jul 1;21(7):3447-3458. doi: 10.1021/acs.molpharmaceut.4c00155. Epub 2024 Jun 6. Mol Pharm. 2024. PMID: 38843446

2

Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1/PD- L1-dependent T cell immunization.

Xu R, Wu J, Zhang X, Zou X, Li C, Wang H, Yuan M, Chen M, Sun Q, Liu S. Xu R, et al. Among authors: yuan m. Pharmacol Res. 2020 Feb;152:104623. doi: 10.1016/j.phrs.2019.104623. Epub 2019 Dec 30. Pharmacol Res. 2020. PMID: 31899315 Clinical Trial.

3

Modified Jian-pi-yang-zheng decoction inhibits gastric cancer progression via the macrophage immune checkpoint PI3Kγ.

Yuan M, Zou X, Liu S, Xu X, Wang H, Zhu M, Xie X, Wang H, Wu J, Sun Q. Yuan M, et al. Biomed Pharmacother. 2020 Sep;129:110440. doi: 10.1016/j.biopha.2020.110440. Epub 2020 Jun 29. Biomed Pharmacother. 2020. PMID: 32768942 Free article.

4

The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.

Chen YZ, Yuan MY, Chen YL, Zhang X, Xu XT, Liu SL, Zou X, Tao JL, Qiang YH, Wu J, Sun QM. Chen YZ, et al. Curr Drug Targets. 2021;22(11):1222-1231. doi: 10.2174/1389450122666210412141304. Curr Drug Targets. 2021. PMID: 33845736 Review.

5

PKM2 Is the Target of a Multi-Herb-Combined Decoction During the Inhibition of Gastric Cancer Progression.

Sun Q, Yuan M, Wang H, Zhang X, Zhang R, Wang H, Chen X, Zhu M, Liu S, Wu J. Sun Q, et al. Among authors: yuan m. Front Oncol. 2021 Dec 2;11:767116. doi: 10.3389/fonc.2021.767116. eCollection 2021. Front Oncol. 2021. PMID: 34926270 Free PMC article.

6

Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes.

Wu J, Yuan M, Shen J, Chen Y, Zhang R, Chen X, Wang H, Yin Z, Zhang X, Liu S, Sun Q. Wu J, et al. Among authors: yuan m. Phytomedicine. 2022 Aug;103:154229. doi: 10.1016/j.phymed.2022.154229. Epub 2022 Jun 2. Phytomedicine. 2022. PMID: 35691076

7

Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling.

Xu X, Li Y, Zhang R, Chen X, Shen J, Yuan M, Chen Y, Chen M, Liu S, Wu J, Sun Q. Xu X, et al. Among authors: yuan m. J Ethnopharmacol. 2023 Jul 15;311:116450. doi: 10.1016/j.jep.2023.116450. Epub 2023 Apr 5. J Ethnopharmacol. 2023. PMID: 37023839

8

Nobiletin inhibits de novo FA synthesis to alleviate gastric cancer progression by regulating endoplasmic reticulum stress.

Chen M, Zhang R, Chen Y, Chen X, Li Y, Shen J, Yuan M, Chen Y, Wu J, Sun Q. Chen M, et al. Among authors: yuan m. Phytomedicine. 2023 Jul 25;116:154902. doi: 10.1016/j.phymed.2023.154902. Epub 2023 May 24. Phytomedicine. 2023. PMID: 37270969

9

Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer.

Zhang R, Chen X, Miao C, Chen Y, Li Y, Shen J, Yuan M, Chen M, Cheng J, Liu S, Sun Q, Wu J. Zhang R, et al. Among authors: yuan m. J Ethnopharmacol. 2024 Jan 10;318(Pt B):117013. doi: 10.1016/j.jep.2023.117013. Epub 2023 Aug 10. J Ethnopharmacol. 2024. PMID: 37572927

10

The potential effect and mechanism of Saikosaponin A against gastric cancer.

Wang C, Zhang R, Chen X, Yuan M, Wu J, Sun Q, Miao C, Jing Y. Wang C, et al. Among authors: yuan m. BMC Complement Med Ther. 2023 Aug 22;23(1):295. doi: 10.1186/s12906-023-04108-3. BMC Complement Med Ther. 2023. PMID: 37608281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,384 results

Search Page

Filters